✨ Medicines and Civil Aviation Notices
NEW ZEALAND GAZETTE, No. 41
12 APRIL 2012
Product:
Apo-Pramipexole
Active Ingredient:
Pramipexole hydrochloride 1mg
Dosage Form:
Tablet
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer:
Apotex Inc, Ontario, Canada
Product:
Hospira™ Cefoxitin Sodium
Active Ingredient:
Cefoxitin sodium 1.051g equivalent to cefoxitin 1g
Dosage Form:
Powder for injection
New Zealand Sponsor:
Hospira NZ Limited
Manufacturer:
Hospira Healthcare India Pvt. Limited, Tamil Nadu, India
Product:
Incivo
Active Ingredient:
Telaprevir 375mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Janssen-Cilag (New Zealand) Limited
Manufacturer:
Janssen-Cilag SpA, Latina, Italy
Dated this 4th day of April 2012.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go2183
Renewal of Provisional Consent to the Distribution of Medicines
Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicines set out in the Schedule hereto:
Schedule
Product:
Atenolol tablets, USP
Active Ingredient:
Atenolol 50mg
Dosage Form:
Tablet
New Zealand Sponsor:
Mylan New Zealand Limited
Manufacturer:
Mylan Pharmaceuticals Inc, West Virginia, United States of America
Note: This renewed consent is valid for six months from 27 May 2012.
Product:
Atenolol tablets, USP
Active Ingredient:
Atenolol 100mg
Dosage Form:
Tablet
New Zealand Sponsor:
Mylan New Zealand Limited
Manufacturer:
Mylan Pharmaceuticals Inc, West Virginia, United States of America
Note: This renewed consent is valid for six months from 27 May 2012.
Dated this 4th day of April 2012.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go2185
Authorities and Other Agencies of State Notices
Civil Aviation Authority of New Zealand
Civil Aviation Act 1990
Civil Aviation Rule Part 71—Designation of Airspace
Pursuant to Civil Aviation Rule Part 71.9(d), the following amendment was designated with effect from 19 April 2012:
- The following new low flying zones are established:
- NZL 364 Waitotara, West Wanganui
- NZL 365, Pauri, East Wanganui
A copy of this amendment is available for viewing at www.caa.govt.nz (NZ Air Navigation Register)
Next Page →
✨ LLM interpretation of page content
🏥
Consent to the Distribution of New Medicines - Apo-Pramipexole, Hospira™ Cefoxitin Sodium, and Incivo
(continued from previous page)
🏥 Health & Social Welfare4 April 2012
Medicines, Apo-Pramipexole, Hospira Cefoxitin Sodium, Incivo, Apotex NZ Limited, Hospira NZ Limited, Janssen-Cilag (New Zealand) Limited
- DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
🏥 Renewal of Provisional Consent to the Distribution of Medicines - Atenolol Tablets
🏥 Health & Social Welfare4 April 2012
Medicines, Atenolol, Mylan New Zealand Limited, Provisional Consent
- DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
🚂 Designation of Airspace - New Low Flying Zones
🚂 Transport & CommunicationsCivil Aviation, Airspace, Low Flying Zones, Waitotara, Pauri
NZ Gazette 2012, No 41